Bank of America Corp DE Has $776,000 Stake in Athenex Inc (ATNX)

Bank of America Corp DE raised its stake in Athenex Inc (NASDAQ:ATNX) by 9.9% in the fourth quarter, Holdings Channel reports. The fund owned 61,097 shares of the company’s stock after purchasing an additional 5,497 shares during the quarter. Bank of America Corp DE’s holdings in Athenex were worth $776,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ATNX. Man Group plc purchased a new position in shares of Athenex in the third quarter worth approximately $201,000. MetLife Investment Advisors LLC lifted its holdings in Athenex by 55.2% during the third quarter. MetLife Investment Advisors LLC now owns 31,296 shares of the company’s stock valued at $486,000 after purchasing an additional 11,125 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Athenex by 8.3% during the third quarter. Vanguard Group Inc. now owns 1,878,063 shares of the company’s stock valued at $29,185,000 after purchasing an additional 144,410 shares in the last quarter. Vanguard Group Inc lifted its holdings in Athenex by 8.3% during the third quarter. Vanguard Group Inc now owns 1,878,063 shares of the company’s stock valued at $29,185,000 after purchasing an additional 144,410 shares in the last quarter. Finally, Teachers Advisors LLC lifted its holdings in Athenex by 4.5% during the third quarter. Teachers Advisors LLC now owns 83,771 shares of the company’s stock valued at $1,302,000 after purchasing an additional 3,585 shares in the last quarter. 31.50% of the stock is owned by institutional investors.

Several equities analysts have weighed in on the stock. BidaskClub raised shares of Athenex from a “sell” rating to a “hold” rating in a report on Tuesday. CIBC assumed coverage on shares of Athenex in a report on Thursday, May 2nd. They set an “outperform” rating and a $20.00 price target on the stock. Oppenheimer assumed coverage on shares of Athenex in a report on Thursday, May 2nd. They set an “outperform” rating and a $20.00 price target on the stock. SunTrust Banks assumed coverage on shares of Athenex in a report on Friday, March 29th. They set a “buy” rating and a $20.00 price target on the stock. Finally, Royal Bank of Canada reaffirmed an “outperform” rating on shares of Athenex in a report on Tuesday, March 12th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $20.00.

Shares of NASDAQ:ATNX opened at $14.02 on Thursday. The company has a current ratio of 2.22, a quick ratio of 2.75 and a debt-to-equity ratio of 0.57. Athenex Inc has a 1-year low of $9.38 and a 1-year high of $20.90. The company has a market cap of $940.27 million, a price-to-earnings ratio of -9.74 and a beta of 0.03.

Athenex (NASDAQ:ATNX) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.45) by ($0.08). The firm had revenue of $25.31 million for the quarter, compared to analysts’ expectations of $19.55 million. Athenex had a negative net margin of 189.86% and a negative return on equity of 96.55%. On average, equities research analysts predict that Athenex Inc will post -1.66 EPS for the current fiscal year.

In related news, CEO Johnson Yiu Nam Lau acquired 10,000 shares of Athenex stock in a transaction dated Monday, March 11th. The shares were purchased at an average price of $11.78 per share, for a total transaction of $117,800.00. Following the completion of the transaction, the chief executive officer now directly owns 2,917,422 shares in the company, valued at approximately $34,367,231.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Perceptive Advisors Llc acquired 100,000 shares of Athenex stock in a transaction dated Monday, May 6th. The shares were bought at an average price of $12.71 per share, for a total transaction of $1,271,000.00. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 157,500 shares of company stock worth $1,967,090 and have sold 132,240 shares worth $1,559,044. Company insiders own 18.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.thestockobserver.com/2019/05/16/bank-of-america-corp-de-has-776000-stake-in-athenex-inc-atnx.html.

About Athenex

Athenex, Inc, a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia. It operates in three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform.

Further Reading: How do taxes affect a CDs total return?

Want to see what other hedge funds are holding ATNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Athenex Inc (NASDAQ:ATNX).

Institutional Ownership by Quarter for Athenex (NASDAQ:ATNX)

Receive News & Ratings for Athenex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athenex and related companies with MarketBeat.com's FREE daily email newsletter.